Pharmacogenetics and Genomics
Pharmacogenetics and Genomics is a journal indexed in SJR in Molecular Biology and Genetics with an H index of 154. It has an SJR impact factor of 0,553 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,553.
Pharmacogenetics and Genomics focuses its scope in these topics and keywords: cypa, cypc, genes, variation, response, adverse, influence, variants, ugtb, therapy, ...
Unclaimed profile — some fields may be incomplete.
Metrics
Campos Scimago / CoP — sin series inventadas
SJR Impact
0,553
H-index
154
Docs (year)
46
Docs 3y
95
Total refs
1642
Cites 3y
167
Citable 3y
91
Cites/Doc 2y
1.62
Ref/Doc
35.7
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Association of multidrug resistance-associated protein 2 single nucleotide polymorphism rs12762549 with the basal plasma levels of phase II metabolites of isoflavonoids in healthy Japanese individuals
View moreVincristine pharmacogenomics
View moreCYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population
View moreCYP2C9 promoter region single-nucleotide polymorphisms linked to the R150H polymorphism are functional suggesting their role in CYP2C9*8-mediated effects
View moreCYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers
View moreCYP1A21*F contains the -163C>A substitution and is highly inducible
View moreCYP1A21*F contains the -163C >A substitution and is highly inducible
View moreComprehensive evaluation of the neuropeptide-Y gene variants in the risk of obesity
View moreComment on Xie et al.
View moreCodeine and morphine pathway
View moreCharacterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient
View moreCerivastatin, genetic variants, and the risk of rhabdomyolysis
View moreBioavailability of testosterone enanthate dependent on genetic variation in the phosphodiesterase 7B but not on the uridine 5'-diphospho-glucuronosyltransferase (UGT2B17) gene.
View moreA comparison of DMET Plus microarray and genome-wide technologies by assessing population substructure
View moreAssociation of (pro)renin receptor gene polymorphism with blood pressure in Caucasian men
View moreAssociation between TAAR6 polymorphisms and airway responsiveness to inhaled corticosteroids in asthmatic patients
View moreAssociation between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients
View moreAngiotensin-converting enzyme activity in Cavalier King Charles Spaniels with an ACE gene polymorphism and myxomatous mitral valve disease
View moreADH4 intronic variations are associated with alcohol dependence
View moreAberrant CYP2D6 metabolizer phenotypes do not show increased frequency in patients undergoing ECT after antidepressant therapy
View moreA systematic analysis and comparison of warfarin initiation strategies
View moreA possible association of the norepinephrine transporter gene in the development of heroin dependence in Han Chinese
View moreA pharmacogene database enhanced by the 1000 Genomes Project
View moreA novel ABCC6 haplotype is associated with azathioprine drug response in myasthenia gravis
View more